179 related articles for article (PubMed ID: 23267792)
1. Adverse effect on syngeneic islet transplantation by transgenic coexpression of decoy receptor 3 and heme oxygenase-1 in the islet of NOD mice.
Huang SH; Lin GJ; Chien MW; Chu CH; Yu JC; Chen TW; Hueng DY; Liu YL; Sytwu HK
Transplant Proc; 2013 Mar; 45(2):580-4. PubMed ID: 23267792
[TBL] [Abstract][Full Text] [Related]
2. Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation.
Huang SH; Chu CH; Yu JC; Chuang WC; Lin GJ; Chen PL; Chou FC; Chau LY; Sytwu HK
Diabetologia; 2010 Nov; 53(11):2389-400. PubMed ID: 20683574
[TBL] [Abstract][Full Text] [Related]
3. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.
Sung HH; Juang JH; Lin YC; Kuo CH; Hung JT; Chen A; Chang DM; Chang SY; Hsieh SL; Sytwu HK
J Exp Med; 2004 Apr; 199(8):1143-51. PubMed ID: 15078896
[TBL] [Abstract][Full Text] [Related]
4. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression.
Han B; Wu J
J Immunol; 2009 Dec; 183(12):8157-66. PubMed ID: 20007581
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of the transgenic expression of human sTNF-αR-Fc and HO-1 on pig-to-mouse islet xenograft survival.
Yan JJ; Yeom HJ; Jeong JC; Lee JG; Lee EW; Cho B; Lee HS; Kim SJ; Hwang JI; Kim SJ; Lee BC; Ahn C; Yang J
Transpl Immunol; 2016 Feb; 34():25-32. PubMed ID: 26777482
[TBL] [Abstract][Full Text] [Related]
6. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
[TBL] [Abstract][Full Text] [Related]
7. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of thioredoxin in islets transduced by a lentiviral vector prolongs graft survival in autoimmune diabetic NOD mice.
Chou FC; Sytwu HK
J Biomed Sci; 2009 Aug; 16(1):71. PubMed ID: 19671194
[TBL] [Abstract][Full Text] [Related]
10. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
Lakey JR; Singh B; Warnock GL; Rajotte RV
Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
[TBL] [Abstract][Full Text] [Related]
11. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
[TBL] [Abstract][Full Text] [Related]
12. Modest effects of Fas-ligand and heme oxygenase-1 double transgenic mouse islets on transplantation outcomes.
Juang JH; Tu CF; Kuo CH
Transplant Proc; 2011 Nov; 43(9):3198-200. PubMed ID: 22099756
[TBL] [Abstract][Full Text] [Related]
13. Impact of donor immune cells in pancreatic islet transplantation.
Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z
Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170
[TBL] [Abstract][Full Text] [Related]
14. Enhanced effect of human mesenchymal stem cells expressing human TNF-αR-Fc and HO-1 gene on porcine islet xenotransplantation in humanized mice.
Lee HS; Song S; Shin DY; Kim GS; Lee JH; Cho CW; Lee KW; Park H; Ahn C; Yang J; Yang HM; Park JB; Kim SJ
Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29135052
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of rat islets transduced with human heme oxygenase-1 gene using adenovirus vector.
Li Y; Li G; Dong W; Chen J; Lu D; Tan J
Pancreas; 2006 Oct; 33(3):280-6. PubMed ID: 17003650
[TBL] [Abstract][Full Text] [Related]
16. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
[TBL] [Abstract][Full Text] [Related]
17. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
[TBL] [Abstract][Full Text] [Related]
18. DcR3/TR6 effectively prevents islet primary nonfunction after transplantation.
Wu Y; Han B; Luo H; Roduit R; Salcedo TW; Moore PA; Zhang J; Wu J
Diabetes; 2003 Sep; 52(9):2279-86. PubMed ID: 12941767
[TBL] [Abstract][Full Text] [Related]
19. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
20. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy.
Wang T; Singh B; Warnock GL; Rajotte RV
Diabetes; 1992 Jan; 41(1):114-7. PubMed ID: 1727730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
